disorders c 11 perspectives treatment -r prev use v types...
TRANSCRIPT
1
CHAPTER 11
SUBSTANCE-RELATED
DISORDERS AND
IMPULSE CONTROL
DISORDERS(PP. 392-437)
1 Substance-Related & Impulse Control
Disorders
Perspectives
Abuse v Dependence
Use v Intoxication
Hallucinogens
Stimulants
AnxiolyticSedative
Hypnotic
Alcohol
Bio
Depressants Opioids
Types
Causes
Prev
Tolerance & Withdrawal
Other
HR
Caffeine
Cocaine
Nicotine
Amphetamines
Designer
Cannabis LSD
Other
Steroids
Inhalants
Socio-Cultural
Psych
Bio
Treatment
PsySoc
Integrated
Impulse Control Disorders
2Last
• Nature of Substance-
Related Disorders
– Problems related to use and
abuse of psychoactive
substances
– Many physiological,
psychological, and
behavioural effects
• Some Terms and
Distinctions
– Substance Use vs. Substance
Intoxication (right)
– Substance Abuse (+1) vs.
Substance Dependence (+2)
– Tolerance vs. Withdrawal
(+2)
PERSPECTIVES ON
SUBSTANCE-RELATED
DISORDERS: AN
OVERVIEW (PP. 393-400)
3 4
5
• Addiction pervasive
– Many Substances AND other Activities Addictive (+1)
– Substances of abuse vary in Addictiveness (+2)
• Five Main Categories of Substances
– Depressants: result in behavioural sedation (e.g., alcohol,
sedative, anxiolytic drugs)
– Stimulants: increase alertness and elevate mood (e.g., cocaine,
nicotine, caffeine)
– Opiates: primarily produce analgesia and euphoria (e.g., heroin,
morphine, codeine)
– Hallucinogens: alter sensory perception (e.g., marijuana, LSD)
– Other: include inhalants, anabolic steroids, medications
PERSPECTIVES ON SUBSTANCE-RELATED
DISORDERS: AN OVERVIEW (PP. 399-400)
6
2
PERSPECTIVES ON
SUBSTANCE-
RELATED
DISORDERS: AN
OVERVIEW (P. 397)
7
PERSPECTIVES ON SUBSTANCE-
RELATED DISORDERS:
AN OVERVIEW (P. 398)
8Map
DEPRESSANTS
• Alcohol Use Disorders
• Sedative, Hypnotic, or
Anxiolytic Substance
Abuse Disorders
– Barbiturates
– Benzodiazepines
9
Alcohol Consumption
• Psychological and Physiological
Effects of Alcohol
– Central Nervous system depressant
– Influences several
neurotransmitter systems, but
mainly GABA
• Effects of Chronic Alcohol Use
– Alcohol intoxication (+1)
– Alcohol withdrawal
– Associated brain conditions (right):
Dementia, Wernicke’s disease
– Liver Disease (+2)
– Fetal alcohol syndrome (+3 +4)
• DSM-IV Criteria for Disordered
Alcohol Use
ALCOHOL USE
DISORDERS (PP. 400-402)
10
11
THE DEPRESSANTS: ALCOHOL USE DISORDERS (P. 400)
12
3
FETAL
ALCOHOL
SYNDROME
13 FETAL ALCOHOL SYNDROME14
• In Canada:
– Most adults drink in moderation
– 20 percent of Ontario population moderate to high risk for alcohol
dependence (Adalf, Ivis, and Smart, 1994)
– about 23% of Canadians exceed low-risk guidelines for alcohol
consumption and about 17 percent classified as high risk drinkers
(Canadian Centre for Substance Abuse [CCSA])
– Men more likely than women to drink and are also more likely to
drink heavily (Statistics Canada, 2003): percent 2 or more drinks
daily (Canada, 2004, graph)
– International Statistics (+1)
ALCOHOL: SOME FACTS AND STATISTICS (PP. 402-405)15 16
• Facts and Statistics on Problem Drinking
– 10% of Americans experience problems with alcohol
– Most persons with alcoholism can moderate or cease drinking on
occasion
– 20% of those with alcohol problems experience spontaneous
recovery
– Anhedonia: Lack of pleasure, or indifference to pleasurable
activities
– Affective flattening: Show little expressed emotion, but may still
feel emotion
• Changes in consumption
– Reduced consumption in many countries, but not all (+1)
ALCOHOL: SOME FACTS AND STATISTICS (PP. 402-405)17 18
4
• The Nature of Drugs in This Class
– Sedatives: calming
– Hypnotic: sleep inducing (e.g., barbiturates)
– Anxiolytic: anxiety reducing (e.g., benzodiazepines)
• Effects similar to large doses of alcohol
– Combining such drugs with alcohol is synergistic
• All exert their influence via GABA Neurotransmitter System
• DSM-IV criteria for sedative, hypnotic, or Anxiolytic
substance use disorders (+1 +2)
SEDATIVE, HYPNOTIC, OR ANXIOLYTIC
SUBSTANCE USE DISORDERS: AN OVERVIEW(PP. 405-406)
19 20DSM-IV-TR CRITERIA FOR SEDATIVE, HYPNOTIC, OR
ANXIOLYTIC INTOXICATION
• A. Recent use of a sedative, hypnotic, or anxiolytic.
• B. Clinically significant maladaptive behavioural or psychological changes (e.g., inappropriate sexual or aggressive behaviour, mood lability, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, sedative, hypnotic, or anxiolytic use.
• C. One (or more) of following signs, developing during, or shortly after, sedative, hypnotic, or anxiolytic use:
– slurred speech
– incoordination
– unsteady gait
– nystagmus
– impairment in attention or memory
– stupor or coma
• D. Symptoms not due to general medical condition and not better accounted for by another mental disorder.
21DSM-IV-TR CRITERIA FOR SEDATIVE, HYPNOTIC OR
ANXIOLYTIC WITHDRAWAL
• A. Cessation of (or reduction in) sedative, hypnotic, or anxiolytic use that has been heavy and prolonged.
• B. Two (or more) of following, developing within several hours to a few days after Criterion A: – autonomic hyperactivity (e.g., sweating or pulse rate greater than 100)
– increased hand tremor
– Insomnia
– nausea or vomiting
– transient visual, tactile, or auditory hallucinations or illusions
– psychomotor agitation
– anxiety
– grand mal seizures
• C. Symptoms in B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
• D. Symptoms not due to general medical condition and not better accounted for by another mental disorder.
• Specify if: With Perceptual Disturbances
Map
• Nature of Stimulants
– Most widely consumed drug in
Canada and United States
– Such drugs increase alertness and
increase energy
– Examples include
• Amphetamines
• Cocaine
• Nicotine
• Caffeine
STIMULANTS: AN OVERVIEW (P. 406)22
• Effects of Amphetamines– Produce elation, vigor, reduce fatigue
– Enhance the release of dopamine and norepinephrine, while blocking
reuptake
– Such effects are followed by a “crash” (e.g., feeling depressed and tired)
• DSM-IV Criteria for Amphetamine Intoxication (+1)– Psychological and Physiological symptoms
• DSM-IV Criteria for Amphetamine Withdrawal (+2)– Psychological and Physiological symptoms
• Ecstasy and Ice– Effects similar to speed, but without the crash
– Recreational use of Ecstasy rose sharply in late 1980s
– Among Toronto students surveyed in 1999, past-year use of Ecstasy was 7%,
the highest rate observed in gradual upward trend since 1991
– Both drugs can result in dependence
STIMULANTS: AMPHETAMINE USE DISORDERS (P.
407)
23 24DSM-IV-TR CRITERIA FOR AMPHETAMINE
INTOXICATION
• A. Recent use of amphetamine or related substance (e.g., methylphenidate).
• B. Clinically significant maladaptive behavioural or psychological changes (e.g., euphoria or affective blunting; changes in sociability; hypervigilance; interpersonal sensitivity; anxiety, tension, or anger; stereotyped behaviours; impaired judgment; or impaired social or occupational functioning) that developed during, or shortly after, use of amphetamine or a related substance.
• C. Two (or more) of following, developing during, or shortly after, use of amphetamine or related substance:
– tachycardia or bradycardia
– pupillary dilation
– elevated or lowered blood pressure
– perspiration or chills
– nausea or vomiting
– evidence of weight loss
– psychomotor agitation or retardation
– muscular weakness, respiratory depression, chest pain, or cardiac arrhythmias
– confusion, seizures, dyskinesias, dystonias, or coma
• D. Symptoms not due to general medical condition and not better accounted for by another mental disorder.
• Specify if: With Perceptual Disturbances
5
25DSM-IV-TR CRITERIA FOR AMPHETAMINE
WITHDRAWAL
• A. Cessation of (or reduction in) amphetamine (or related substance) use that has been heavy and prolonged.
• B. Dysphoric mood and two (or more) of following physiological changes, developing within few hours to several days after Criterion A
– Fatigue
– Vivid, unpleasant dreams
– Insomnia or Hypersomnia
– Increased appetite
– Psychomotor retardation or agitation
• C. Symptoms in B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
• D. Symptoms not due to general medical condition and not better accounted for by another mental disorder.
• Effects of Cocaine
– Produce short lived sensations of elation, vigor, reduce fatigue
– Effects result from blocking the reuptake of dopamine (+1)
– Cocaine is highly addictive, but addiction develops slowly
– Cocaine use in Canada has declined over the last decade
• DSM-IV Criteria for Cocaine Intoxication (+2) and
Withdrawal
– Psychological symptoms
– Physiological symptoms
– Most cocaine users cycle through patterns of tolerance and
withdrawal
STIMULANTS: COCAINE USE DISORDERS (PP. 407-409)26
COCAINE BLOCKS DOPAMINE REUPTAKE 27 28
• Effects of Nicotine
– Stimulates Central Nervous System, specifically nicotinic
acetylcholine receptors
– Results in sensations of relaxation, wellness, pleasure
– Nicotine highly addictive; relapse rates high (+1)
• DSM-IV Criteria for Nicotine Withdrawal Only
– Psychological and Physiological symptoms
– Nicotine users dose themselves to maintain steady state of
nicotine
• & Psychological
Disorders
NICOTINE USE DISORDERS (PP. 409-410) 29
STIMULANTS:
NICOTINE USE
DISORDERS (P. 410)
30
6
• Effects of Caffeine – The
“Gentle” Stimulant
– Found in tea, coffee, cola drinks,
and cocoa products
– Caffeine blocks reuptake of
neurotransmitter adenosine
– Small doses elevate mood and
reduce fatigue
– Used by over 90% of Americans
– Regular use can result in tolerance
and dependence (+1)
• DSM-IV Criteria for Caffeine
Intoxication
– Psychological and Physiological
symptoms (+2)
CAFFEINE USE
DISORDERS (PP. 410-411)
31 32• Caffeine mildly addictive, as indicated by Withdrawal
Symptoms, even when moderate amounts of caffeine are
withdrawn for 18 to 24 hours
– Symptoms include: Headache, Fatigue, Irritability, Depression, and
Poor Concentration
– Symptoms peak within 24 to 48 hours and progressively decrease
over course of a week
– To minimize withdrawal symptoms, experts recommend reducing
caffeine intake gradually
33
Map
• The Nature of Opiates and Opioids– Opiate: natural chemical in opium poppy
with narcotic effects (i.e., pain relief)
– Opiods: class of natural and synthetic
substances with narcotic effects
– Often referred to as analgesics
– e.g., heroin, opium, codeine, morphine
• Effects of Opioids– Activate body’s enkephalins and
endorphins
– Low doses induce euphoria, drowsiness,
and slowed breathing
– High doses can result in death
– High mortality due to various causes:
homicide, suicide, overdose, HIV (+1)
• DSM: Intoxication & Withdrawal (+2 +3)
– Withdrawal can be lasting and severe
OPIOIDS(PP. 411-412)
34
35IDUs % HIV Cases 36
7
37DSM-IV-TR CRITERIA FOR OPIOD WITHDRAWAL
• A. Either of following: – cessation of (or reduction in) opioid use that has been heavy and prolonged (several
weeks or longer)
– administration of opioid antagonist after period of opioid use
• B. Three (or more) of following, developing within minutes to several days after A: – dysphoric mood
– nausea or vomiting
– muscle aches
– lacrimation or rhinorrhea
– pupillary dilation, piloerection, or sweating
– diarrhea
– yawning
– fever
– Insomnia
• C. Symptoms in B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
• D. Symptoms not due to general medical condition and not better accounted for by another mental disorder.
Map • Nature of Hallucinogens– Substances that change way user perceives
world
– May produce delusions, paranoia,
hallucinations, and altered sensory perception
– e.g., Marijuana, LSD
• Marijuana– Active chemical is tetrahydrocannabinol (THC)
– May produce several symptoms: e.g., mood
swings, paranoia, hallucinations (+1)
– Impairment in motivation is not uncommon: i.e.,
amotivational syndrome
– Major signs of withdrawal and dependence do
not typically occur
– Perhaps some link with heavy use and
schizophrenia (+2)
HALLUCINOGENS (PP. 412-415) 38
39 CANNABIS & SCHIZOPHRENIA40
• LSD and Other Hallucinogens
– LSD is most common form of
hallucinogenic drug
– Tolerance tends to be rapid, and
withdrawal symptoms are
uncommon
– Psychotic delusional and
hallucinatory symptoms can be
problematic
• DSM-IV Criteria for
Hallucinogen Intoxication
– Similar psychological and
physiological symptoms to
Marijuana
HALLUCINOGENS (PP. 412-415) 41
Map
42OTHER DRUGS OF ABUSE
• Other Drugs
– Do not fit into
previous classes
– Cause physical damage
to users
– Examples include:
• Inhalants
• Steroids
• Designer Drugs
8
OTHER DRUGS OF ABUSE: INHALANTS(PP. 415-416)
• Nature of Inhalants
– Substances found in volatile
solvents breathed into lungs
directly
– e.g.,: spray paint, hair spray,
paint thinner, gasoline,
nitrous oxide
– Rapidly absorbed with
effects similar to alcohol
intoxication
– Tolerance and prolonged
symptoms of withdrawal are
common
– DSM-IV criteria for inhalant
intoxication(+1)
• Statistics
– MB 2007 drug survey: 55
schools, 4,992 students; in
past year, 3.7% from grades 7
to senior 4 had used inhalants
– 2009 Ontario Drug Use Survey:
5.3% of students from grades
7 to 12 had used solvents.
– 2008 USA study: 8.9% of grade
8 students, 5.9% of grade 10
students and 3.8% of grade 12
students had abused inhalants
at least once in past year.
– Serious problem in isolated
communities (e.g., reserves) in
Canada (+2)
43 44DSM-IV-TR CRITERIA FOR INHALANT INTOXICATION
• A. Recent intentional use or short-term, high-dose exposure to volatile inhalants (excluding anesthetic gases and short-acting vasodilators).
• B. Clinically significant maladaptive behavioural or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, use of or exposure to volatile inhalants.
• C. Two (or more) of following signs, developing during, or shortly after, inhalant use or exposure:
– dizziness
– nystagmus
– incoordination
– slurred speech
– unsteady gait
– lethargy
– depressed reflexes
– psychomotor retardation
– tremor
– generalized muscle weakness
– blurred vision or diplopia
– stupor or coma
– euphoria
• D. Symptoms not due to general medical condition and not better accounted for by another mental disorder.
45• CBC program on children sniffing
gasoline in Innu community of
Shesatshiu, Newfoundland and
Labrador
– Sniffing produces highs similar to
alcohol
– Children report stealing
snowmobiles to sniff gasoline,
staying out sniffing rather than
going home, …
– One boy burned to death when gas
caught fire
– Children report suicidal thoughts
• Nature of Anabolic-Androgenic
Steroids
– Steroids are derived or synthesized
from testosterone
– Used medicinally or to increase
body mass
– Users may engage in cycling or
stacking
– Steroids do not produce a high
– Steroids can result in long-term
mood disturbances and physical
problems
– Major problem in competitive sports
OTHER DRUGS OF ABUSE:
ANABOLIC STEROIDS (P. 416)
46
• Designer Drugs
– Drugs produced by
pharmaceutical companies
for diseases
– Ecstasy, MDEA (“eve”),
BDMPEA (“nexus”), ketamine
(“special K”) are examples
– Heighten auditory and visual
perception, sense of
taste/touch
– Popular in nightclubs, raves,
or large social gatherings
– All designer drugs can
produce tolerance and
dependence; some judged to
be harmful (left graph)
OTHER DRUGS OF ABUSE:
DESIGNER DRUGS (P. 416)
47
Map
• Family, Twin, and Adoption Studies
– Substance abuse has a genetic component
• Heritability higher for higher levels of abuse (+1 +2): MZ > DZ
for Dependence, MZ = DZ for Use
– Much of focus has been on alcoholism
• Results clear for Males (+3), less so for females (+4)
• Heritability (h2): .38 to .70 for Males, .00 to .64 for Females
• Genetic differences in alcohol metabolism
– Multiple genes involved in substance abuse
• Perhaps biological differences across cultures?
– E.g., ALDH2 deficiency in 50% Asians leads to “flushing” and
other effects after alcohol consumption
CAUSES OF SUBSTANCE-RELATED DISORDERS:
FAMILY AND GENETIC INFLUENCES (PP. 416-417)
48
9
49 50
51
TWIN STUDIES ALCOHOLISM: MALES51
52
TWIN STUDIES ALCOHOLISM: FEMALES52
• Results of Neurobiological Research
– Drugs affect pleasure or reward centers in brain
– The pleasure center: dopamine, midbrain, frontal cortex
– GABA turns off reward-pleasure system
– Neurotransmitters responsible for anxiety/negative affect may be
inhibited
CAUSES OF SUBSTANCE-RELATED DISORDERS:
NEUROBIOLOGICAL INFLUENCES (PP. 417-418)
53
• Role of Positive and Negative Reinforcement
– Self-medication and tension reduction hypotheses
– Most see substance abuse as means to cope with negative affect
• Opponent-Process Theory (+1)
– Positive reactions to drug countered by Negative reaction to
restore neutral state. Negative reaction strengthens (hence
tolerance) and dominates when drug absent (hence withdrawal)
– Explains why crash after drug use fails to stop use
• Role of Expectancy Effects
– Expectancies influence drug use and relapse
• Alcohol myopia
– Shortsighted focus on superficial, immediate aspects of
experience; take health risks (e.g., unprotected sex)
CAUSES OF SUBSTANCE-RELATED DISORDERS:
PSYCHOLOGICAL DIMENSIONS (PP. 418-419)
54
10
OPPONENT-PROCESS THEORY55 56CAUSES: SOCIAL & CULTURAL DIMENSIONS
PP 420-422
• Cultural Norms
– Influence use and manifestation of substance abuse
• e.g., Koreans expect to drink heavily on some social occasions
– Exposure to drugs varies across culture: e.g., smoking, alcohol
consumption, ..
• Exposure to Drugs is a Prerequisite for Use of Drugs
– Media, family, peers
– Parents and family appear critical
• Societal Views About Drug Abuse
– Sign of moral weakness: drug abuse is failure of self-control
– Sign of disease: drug abuse caused by some underlying process
• Statistics on Use and Abuse
– Abuse varies across nations and by ethnicity (+1)
EXCESSIVE ALCOHOL USE57
• Integrated Model (+1)
– Exposure or access to drug is necessary, but not sufficient
– Use depends on social and cultural expectations
– Used for pleasurable effects
– Abused for reasons that are more complex
• The premise of equifinality
• Stress may interact with psychological, genetic, social, and
learning factors
AN INTEGRATIVE MODEL OF SUBSTANCE-RELATED
DISORDERS (P. 422)
58
AN INTEGRATIVE MODEL OF SUBSTANCE-
RELATED DISORDERS (P. 422)
59
Map
• Biological Treatments
• Psychosocial Treatments
TREATMENT FOR SUBSTANCE ABUSE DISORDERS60
11
• Agonist Substitution
– Safe drug with similar chemical composition as abused drug
– e.g., methadone for heroin addiction, and nicotine gum or patch
• Antagonistic Treatment
– Drugs that block or counteract positive effects of substances
– e.g., naltrexone for opiate and alcohol problems
• Aversive Treatment
– Drugs that make injection of abused substances unpleasant
– e.g., antabuse for alcoholism, silver nitrate for nicotine addiction
• Efficacy
– Such treatments generally not effective when used alone
BIOLOGICAL TREATMENT OF SUBSTANCE-RELATED
DISORDERS (PP. 423-425)
61
• Debate over controlled use vs. complete abstinence as
treatment goals
• Inpatient vs. Outpatient Care
– Data suggest little difference in terms of overall effectiveness
• Community Support Programs
– Alcoholics Anonymous and related groups
– Seem helpful and are strongly encouraged
– But difficulty evaluating efficacy (effectiveness): anonymity, high
drop out rates, …
– Some principles contrary to psychological principles: e.g., giving
over control to “higher power” vs. taking responsibility (+1)
PSYCHOSOCIAL TREATMENT OF SUBSTANCE-
RELATED DISORDERS (PP. 425-428)
62
63
• Components of Comprehensive Treatment and Prevention
Programs
– Individual and group therapy
– Aversion therapy and covert sensitization
– Contingency management
– Community reinforcement
– Treatment matching (+1)
– Relapse prevention
• Harm reduction
– Reduce negative consequences
– e.g., Safe Injection Sites
• Prevention efforts through education
PSYCHOSOCIAL TREATMENT OF
SUBSTANCE-RELATED DISORDERS (PP. 425-429)
64
65
• Conrod et al
(2000)
• Matched or
not on
motivation /
personality
• Anxiety
Sensitivity
• Hopelessness
• Impulsivity
• Sensation
Seeking
Map
• Many substance abuse disorders start with irresistible impulse
• DSM-IV-TR includes five additional impulse-control disorders:
“impulse-control disorders not elsewhere classified”– Intermittent Explosive Disorder: act on aggressive impulses that result in
serious assaults or destruction of property.
– Kleptomania: recurrent failure to resist urges to steal things that are not
needed for personal use or their monetary value.
– Pyromania: irresistible urge to set fires.
– Pathological Gambling: cannot control impulse to gamble
– Trichotillomania: irresistible urge to pull out own hair from anywhere on
body, including scalp, eyebrows, and arms.
IMPULSE-CONTROL DISORDERS (PP. 429-431) 66
12
67Map
• DSM-IV and DSM-IV TR Substance Related Disorders Cover Four
Classes– Depressants, Stimulants, Opiates, and Hallucinogens (+1)
– Specific diagnoses include dependence, abuse, intoxication, and
withdrawal
• Most psychotropic drugs activate dopaminergic pleasure pathway
in brain
• Psychosocial factors interact with biological influences to produce
substance disorders (+2)
• Treatment of Substance Dependence largely unsuccessful – Highly motivated persons do best when part of combined treatment
programs (+3)
• Substance-related disorders are 100% preventable
• Other Impulse Control Disorders (+4)
SUMMARY OF SUBSTANCE-RELATED DISORDERS (P.
434)
68
69 70
71 72
Map